- Filed
- Aug 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Jun 28, 2025 | 54.8M sh |
| Shares Diluted | Q2 2025 · Jun 28, 2025 | 54.9M sh |
| Shares Diluted | Q2 2025 · Jun 29, 2024 | 54.3M sh |
| Shares Diluted | Q2 2025 · Jun 29, 2024 | 54.3M sh |
| Shares Outstanding | Q2 2025 · Jun 28, 2025 | 54.32M sh |
| Stock Repurchased | Q2 2025 · Jun 28, 2025 | $13.7M |
| Stock Repurchased | Q2 2025 · Jun 29, 2024 | $0 |
| Capex | Q2 2025 · Jun 28, 2025 | $6.4M |
| Capex restated | Q2 2025 · Jun 29, 2024 | $9.7M |
| Operating Cash Flow | Q2 2025 · Jun 28, 2025 | $100.5M |
| Operating Cash Flow | Q2 2025 · Jun 29, 2024 | $120.3M |
| Long Term Debt | Q2 2025 · Jun 28, 2025 | $598.7M |
| Long Term Debt | Q2 2025 · Dec 28, 2024 | $714.3M |
| Short Term Debt | Q2 2025 · Jun 28, 2025 | $15M |
| Short Term Debt | Q2 2025 · Dec 28, 2024 | $15M |
| Cash And Equivalents | Q2 2025 · Jun 28, 2025 | $149.6M |
| Cash And Equivalents | Q2 2025 · Dec 28, 2024 | $123.6M |
| Stockholders Equity | Q2 2025 · Jun 28, 2025 | $1.04B |
| Stockholders Equity | Q2 2025 · Mar 29, 2025 | $946.4M |
| Stockholders Equity | Q2 2025 · Dec 28, 2024 | $1.05B |
| Stockholders Equity | Q2 2025 · Jun 29, 2024 | $1.37B |
| Stockholders Equity | Q2 2025 · Mar 30, 2024 | $1.37B |
| Stockholders Equity | Q2 2025 · Dec 30, 2023 | $1.36B |
| Current Liabilities | Q2 2025 · Jun 28, 2025 | $592.1M |
| Current Liabilities | Q2 2025 · Dec 28, 2024 | $617.7M |
| Total Liabilities | Q2 2025 · Jun 28, 2025 | $1.36B |
| Total Liabilities | Q2 2025 · Dec 28, 2024 | $1.57B |
| Current Assets | Q2 2025 · Jun 28, 2025 | $1.27B |
| Current Assets | Q2 2025 · Dec 28, 2024 | $1.23B |
| Total Assets | Q2 2025 · Jun 28, 2025 | $2.4B |
| Total Assets | Q2 2025 · Dec 28, 2024 | $2.63B |
| Eps Diluted | Q2 2025 · Jun 28, 2025 | $0.94 |
| Eps Diluted | Q2 2025 · Jun 28, 2025 | −$2.17 |
| Eps Diluted restated | Q2 2025 · Jun 29, 2024 | $0.30 |
| Eps Diluted | Q2 2025 · Jun 29, 2024 | $0.64 |
| Eps Basic | Q2 2025 · Jun 28, 2025 | $0.95 |
| Eps Basic | Q2 2025 · Jun 28, 2025 | −$2.21 |
| Eps Basic | Q2 2025 · Jun 29, 2024 | $0.30 |
| Eps Basic | Q2 2025 · Jun 29, 2024 | $0.66 |
| Sga Expense | Q2 2025 · Jun 28, 2025 | $138.9M |
| Sga Expense | Q2 2025 · Jun 28, 2025 | $258.3M |
| Sga Expense restated | Q2 2025 · Jun 29, 2024 | $126.3M |
| Sga Expense restated | Q2 2025 · Jun 29, 2024 | $242M |
| Rd Expense | Q2 2025 · Jun 28, 2025 | $29.9M |
| Rd Expense | Q2 2025 · Jun 28, 2025 | $63.8M |
| Rd Expense restated | Q2 2025 · Jun 29, 2024 | $39.1M |
| Rd Expense restated | Q2 2025 · Jun 29, 2024 | $76.8M |
| Net Income | Q2 2025 · Jun 28, 2025 | $51.3M |
| Net Income | Q2 2025 · Jun 28, 2025 | −$119.4M |
| Net Income | Q2 2025 · Mar 29, 2025 | −$170.7M |
| Net Income | Q2 2025 · Jun 29, 2024 | $16M |
| Net Income | Q2 2025 · Jun 29, 2024 | $34.9M |
| Net Income | Q2 2025 · Mar 30, 2024 | $18.9M |
| Operating Income | Q2 2025 · Jun 28, 2025 | $64.5M |
| Operating Income | Q2 2025 · Jun 28, 2025 | $142.5M |
| Operating Income restated | Q2 2025 · Jun 29, 2024 | $41.9M |
| Operating Income restated | Q2 2025 · Jun 29, 2024 | $95.1M |
| Gross Profit | Q2 2025 · Jun 28, 2025 | $233.3M |
| Gross Profit | Q2 2025 · Jun 28, 2025 | $467.3M |
| Gross Profit restated | Q2 2025 · Jun 29, 2024 | $207.3M |
| Gross Profit restated | Q2 2025 · Jun 29, 2024 | $413.9M |
| Cost Of Revenue | Q2 2025 · Jun 28, 2025 | $137.6M |
| Cost Of Revenue | Q2 2025 · Jun 28, 2025 | $275.6M |
| Cost Of Revenue restated | Q2 2025 · Jun 29, 2024 | $136.6M |
| Cost Of Revenue restated | Q2 2025 · Jun 29, 2024 | $269.6M |
| Revenue | Q2 2025 · Jun 28, 2025 | $370.9M |
| Revenue | Q2 2025 · Jun 28, 2025 | $742.9M |
| Revenue restated | Q2 2025 · Jun 29, 2024 | $343.9M |
| Revenue restated | Q2 2025 · Jun 29, 2024 | $683.5M |